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a b s t r a c t
Endolysins are lytic enzymes encoded by bacteriophage that represent an emerging class of protein
therapeutics. Considering macromolecular thermoresistance correlates with shelf life, PlyG, a Bacillus
anthracis endolysin, was thermally characterized to further evaluate its therapeutic potential. Results
from a biophysical thermal analysis revealed full-length PlyG and its isolated domains comprised
thermal denaturation temperatures exceeding 63 1C. In the absence of reducing agent, PlyG was
determined to be kinetically unstable, a ﬁnding hypothesized to be attributable to the chemical
oxidation of cysteine and/or methionine residues. The presence of reducing agent kinetically stabilized
the endolysin, with PlyG retaining at least 50% residual lytic activity after being heated at
temperatures up to 80 1C and remaining enzymatically functional after being boiled. Furthermore, the
endolysin had a kinetic half-life at 50 1C and 55 1C of 35 and 5.5 h, respectively. PlyG represents a
thermostable proteinaceous antibacterial with subsequent prolonged therapeutic shelf life expectancy.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Bacillus anthracis is a Gram-positive spore-forming bacterium
responsible for the zoonotic disease anthrax. In addition to causing
naturally occurring anthrax, B. anthracis has been identiﬁed as a
prominent biological warfare agent. This particular pathogen
remains a public health concern due to the elevated mortality
associated with the airborne transmission of sporulated B. anthra-
cis, as well as diagnostic complications and the ability of
B. anthracis to resist environmental extremes, irradiation, and
antiseptics (Clery-Barraud et al., 2004). Consequently, develop-
ment of diagnostic and therapeutic measures speciﬁc for
B. anthracis remains an active area of investigation.
Bacteriophage-encoded endolysins are emerging antimicrobial
agents that have been effectively exploited against Gram-positive
bacteria (Nelson et al., 2012; Schmelcher et al., 2012a). During the
lytic bacteriophage (i.e. phage) infection cycle, most endolysins
accumulate in the cytosol of host cells. In response to a genetically
speciﬁed signal, holin proteins produced by the phage oligomerize
on the plasma membrane of the bacterium to form pores, allowing
endolysins access to their peptidoglycan substrate (Fischetti, 2011;
Wang et al., 2000; Young, 1992). These enzymes then cleave
critical covalent bonds within the cell wall structure upon direct
contact to rapidly induce osmotic lysis and simultaneous progeny
virion release. Due to the extrinsic accessibility of peptidoglycan
comprised by Gram-positive bacteria, the exogenous therapeutic
application of endolysins is an antibacterial strategy that has been
repeatedly validated in vitro and in vivo against drug-susceptible
and – resistant Gram-positive bacterial strains (Nelson et al., 2001;
Stark et al., 2010). The high binding afﬁnity displayed by endoly-
sins towards unique cognate cell wall-associated epitopes (KA¼
108 to 109 M1) demonstrates their target speciﬁcity and
thereby reduces the risk of resistance development commonly
associated with broad-spectrum classical antibiotics (Schmelcher
et al., 2010; Schuch et al., 2002).
The B. anthracis gamma phage endolysin PlyG is an N-acetyl-
muramoyl-L-alanine amidase, consisting of an N-terminal enzyma-
tically active domain (EAD) linked to a C-terminal cell wall binding
domain (CBD) (Kikkawa et al., 2008; Schuch et al., 2002). The CBD
binds with high afﬁnity to secondary cell wall polysaccharides
explicit to both sporulated and vegetative forms of B. anthracis, as
well as related Bacillus cereus strains (Ganguly et al., 2013; Yang
et al., 2012). The therapeutic potential of PlyG was initially
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evaluated in 2002, which collectively involved resistance studies
and determining whether vegetative bacilli and germinating spores
were susceptible to the enzyme (Schuch et al., 2002). With or
without the presence of the mutagenic compound methane-
sulphonic acid ethyl ester (EMS), repeated exposure of bacilli to
low or high concentrations of PlyG did not generate any endolysin-
resistant strains. In a kinetic analysis, PlyG signiﬁcantly reduced
Bacillus viability when extrinsically applied to either vegetative cells
or germinating spores. The therapeutic potential of the endolysin
was additionally validated in vivo, demonstrating an ability to
rescue Bacillus-infected mice when intraperitoneally administered
15 min after infection (Schuch et al., 2002).
To further evaluate its potential for development as an anti-
microbial agent against B. anthracis, we investigated the thermal
properties of PlyG by circular dichroism spectroscopy, differential
scanning calorimetry and thermal kinetic inactivation analysis as a
platform for projecting shelf life and product stability. The intrinsic
thermal stability of any protein therapeutic is a deﬁning molecular
characteristic that dictates its downstream applicability. As pre-
scribed by the Arrhenius equation, the level of thermoresistance
displayed by a macromolecule correlates with its shelf life
(Anderson and Scott, 1991). In addition to the full-length endoly-
sin, we assessed the thermal stability of the EAD and CBD modules
of PlyG. Explicating the thermal properties of a protein therapeu-
tic, such as PlyG, will provide information relevant to its future
pharmaceutical or biotechnological use.
Results
Protein puriﬁcation of PlyG constructs
Full-length PlyG (residues 1–233), as well as the isolated
N-terminal PlyG_EAD (residues 1–160) and C-terminal PlyG_CBD
(residues 156–233), were expressed and puriﬁed to homogeneity
based on sodium dodecyl sulfate polyacrylamide gel electrophor-
esis (SDS-PAGE) analysis (Fig. 1). As previously described, adding
the 12 amino acid leader sequence modiﬁcation MRGSHHHHHHGS
to the amino-terminal of each construct allowed for a single
immobilized metal afﬁnity chromatography puriﬁcation step to
achieve high purity (Loessner et al., 1996). The residue coordinates
pertaining to each PlyG construct were selected based on ﬁndings
from preceding studies, which collectively suggest each protein
sample exists as a soluble monomer in solution and retains
biologic functionality in the presence of its cell wall receptor
and/or substrate (Low et al., 2011; Mo et al., 2012; Schuch et al.,
2002). Each puriﬁed sample was stored in phosphate buffered
saline (PBS), pH 7.2, supplemented with 20% glycerol at 80 1C
until further needed.
PlyG secondary structure composition and stability as a function
of pH
Using circular dichroism (CD) spectroscopy, the inﬂuence of pH
on PlyG structure and stability was investigated. First, the second-
ary structure composition of the endolysin was determined in
20 mM sodium phosphate buffer, pH 6.0–8.0. Signiﬁcant changes
in secondary structure would seemingly have implications on the
thermal stability of the enzyme. In the pH environments tested,
qualitative analysis of the spectra obtained by means of far-
ultraviolet (UV) CD spectroscopy revealed PlyG is primarily α/β
structured, with an ellipticity maximum observed at 195 nm and
minima observed at 208 and 222 nm (Fig. 2). Next, the aforemen-
tioned far-UV CD spectra were deconvoluted using the CONTIN
method to calculate secondary structure composition. Results
suggest there were no substantial modiﬁcations in the regular
α-helical (73.5%), distorted α-helical (71.5%), regular β-strand
(72.5%), distorted β-strand (70.8%), turn (72.5%) and unordered
(70.8%) structural composition of PlyG in the pH range investi-
gated (Table 1).
The structural stability of PlyG in 20 mM sodium phosphate
buffer, pH 6.0–8.0, was measured using CD thermal denaturation
experiments. All of the samples displayed a single thermally-induced
unfolding transition (Fig. 3). In the pH range tested, PlyG was most
structurally stabilized at pH 6.0, depicting a T1/2, which corresponds
to the temperature at which the concentration of the folded and
unfolded protein fractions are equal, of 64 1C. At pH 6.5, 7.0, 7.5 and
8.0, PlyG comprised respective T1/2 values of 63 1C, 62 1C, 59 1C and
57 1C. Although the possibility exists where PlyG could display
intensiﬁed or weakened structural stability at pH values exceeding
pH 6.0–8.0, the ΔT1/2 when comparing the most stabilizing (i.e. pH
6.0) and destabilizing (i.e. pH 8.0) pH environments analyzed in this
study was 7 1C. With this in mind, subsequent thermal analyses of
PlyG and its domains were elucidated in pH 6.0 buffers.
PlyG_EAD and PlyG_CBD CD thermal denaturation analysis
CD experiments were next utilized to determine the secondary
structure and structural stability of the EAD and CBDmodules of PlyG
Fig. 1. SDS-PAGE analysis of the puriﬁed PlyG constructs. The homogeneity of the
(1) 28 kDa full-length PlyG, (2) 19 kDa PlyG_EAD and (3) 10 kDa PlyG_CBD IMAC
puriﬁed samples was assessed on a 4–15% gradient SDS-PAGE gel.
Fig. 2. Secondary structure analysis of PlyG in pH 6.0–8.0 buffers. CD spectra were
obtained in the far-UV range (190–260 nm) for PlyG samples in 20 mM sodium
phosphate buffer, pH 6.0–8.0. The mean residue ellipticity [θ] (deg cm2 dmol1)
was plotted against the wavelength (nm) for each sample.
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in 20 mM sodium phosphate buffer, pH 6.0. The far-UV spectra
obtained for the isolated EAD and CBD modules of PlyG dictates each
domain comprises an α/β fold (data not shown). The two spectra
additively reconstruct the spectra speciﬁc to PlyG, suggesting each
domain, either isolated or in the context of the full-length endolysin,
adopt similar folds. The EAD and CBD, both of which exhibit single
structural transitions, displayed thermally-induced T1/2 values of
66 1C and 72 1C, respectively (Fig. 4). When compared to the full-
length enzyme, the isolated EAD and CBD depict respective structural
stability enhancements of 2 1C and 8 1C.
Differential scanning calorimetry
Each PlyG construct was subjected to differential scanning
calorimetry (DSC) in 20 mM sodium phosphate buffer, pH 6.0, to
further validate the CD thermal denaturation experimental data.
DSC was also used to potentially identify any thermally-induced
physical or chemical changes to the protein samples that do not
provoke a loss in secondary structure. The complete thermal
denaturation of each protein sample fulﬁlled a three-state thermal
transition model. As dictated by the absence of changes in
heat capacity upon cooling, the thermally-induced unfolding of
each sample was irreversible following heat denaturation. The
unfolding of PlyG consisted of an initial endothermic event with a
respective thermal transition temperature (TG1) and van't Hoff
enthalpy (ΔHVH1) of 64 1C and 150 kcal/mol, as well as a second
endothermic event with a respective thermal transition temperature
(TG2) and van't Hoff enthalpy (ΔHVH2) of 66 1C and 294 kcal/mol
(Fig. 5A). The unfolding of the individual EAD module resulted in two
endothermic transitions that comprised respective TG1 and TG2 values
of 65 1C and 68 1C, with a corresponding ΔHVH1 and ΔHVH2 of
158 kcal/mol and 307 kcal/mol (Fig. 5B) The unfolding of the isolated
CBD of PlyG constituted an initial endothermic transition with a
respective TG1 andΔHVH1 of 68 1C and 91 kcal/mol, and a subsequent
second endothermic transition that encompassed a TG2 andΔHVH2 of
73 1C and 140 kcal/mol, respectively (Fig. 5C). The composite results
from the DSC analysis suggest the EAD and CBD are thermodynami-
cally stabilized by 1 1C and 4 1C, respectively, over the full-length
endolysin.
Kinetic inactivation temperature screen
After assessing the structural and thermodynamic stability of
the various PlyG constructs, the integrity of the catalytic mechan-
ism of the endolysin was analyzed as a function of temperature at
pH 6.0. Results from the kinetic inactivation temperature screen
revealed the kinetic stability of PlyG at pH 6.0 was signiﬁcantly
less than the biophysically-derived structural and thermal transi-
tion temperatures (Fig. 6A). For example, at pH 6.0, PlyG was
shown to have a T1/2 and TG of 64 1C. Conversely, heating PlyG at
the same pH provoked the endolysin to exhibit substantial activity
defects at 40 1C, while retaining less than 50% activity after being
heated at or exceeding 50 1C.
A thermally-induced chemical modiﬁcation to one or more
amino acids could be the reason for the deviation in results
obtained by the biophysical and kinetic thermal analysis of PlyG.
For instance, the amino acids methionine and cysteine can
undergo oxidation when exposed to elevated temperatures,
whereas asparagine and glutamine are susceptible to deamination
(Fukuchi and Nishikawa, 2001; Russell, 1997). To determine if the
inherent kinetic instability of PlyG could be due to methionine
and/or cysteine oxidation, which is representative of a chemical
modiﬁcation known to induce a loss in enzymatic bioactivity and
reduce half-life (Diez-Martinez et al., 2013; Fucci et al., 1983;
Stadtman, 1990), a kinetic inactivation temperature screen was
repeated with one modiﬁcation. In these experiments, the
Table 1
Secondary structure compositional analysis of PlyG in pH 6.0–8.0 buffers.
PlyG αR
(%)
αD
(%)
βR
(%)
βD
(%)
Turns
(%)
Unordered
(%)
Total
(%)
NRMSD
pH 6.0 13.0 11.4 16.8 9.3 19.8 29.7 100.0 0.039
pH 6.5 13.9 10.4 18.2 9.4 18.5 29.6 100.0 0.039
pH 7.0 10.4 10.6 18.3 10.1 20.5 30.1 100.0 0.062
pH 7.5 11.5 11.9 15.8 9.4 21.0 30.4 100.0 0.094
pH 8.0 11.3 11.6 16.8 9.6 20.6 30.0 99.9 0.072
αR – regular α-helix.
αD – distorted α-helix.
βR – regular β-strand.
βD – distorted β-strand.
NRMSD – normalized root mean square deviation.
Fig. 3. Structural stability of PlyG in pH 6.0–8.0 buffers. CD thermal denaturation
experiments were used to determine the structural stability of PlyG in 20 mM
sodium phosphate buffer, pH 6.0–8.0, as a function of temperature. The ellipticity at
222 nm was measured from 20 1C to 95 1C using a heating rate of 1 1C/min. The
normalized ellipticity was then plotted against the temperature to construct the
thermal denaturation curves.
Fig. 4. PlyG_EAD and PlyG_CBD structural stability. The structural stability of the
isolated EAD and CBD modules of PlyG was elucidated using CD thermal
denaturation experiments. In 20 mM sodium phosphate buffer, pH 6.0, both
domains were heated from 20 1C to 95 1C at 1 1C/min, with the ellipticity at
222 nm being monitored. The normalized ellipticity was then plotted against the
temperature to construct the thermal denaturation curves.
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incubation buffer was supplemented with 10 mM tris(2-carbox-
yethyl)phosphine (TCEP) reducing agent. At pH 6.0, the kinetic
stability of PlyG in the presence of reducing agent was substan-
tially augmented when compared to stability displayed in the
absence of reducing agent (Fig. 6B). Reduced PlyG retained more
than 90% residual lytic activity at 50 1C, with activity defects
corresponding to more than a 20% loss in activity not observed
until temperatures exceeded 60 1C. Maintaining cysteine and
methionine residues in a reduced state caused PlyG to display a
kinetic stability phenotype that resembles the biophysically-
derived thermal characteristics. For example, the temperature at
which reduced PlyG lost approximately 50% residual lytic activity
at pH 6.0 (51% loss in activity at 70 1C) relatively coincides with the
identiﬁed CD thermal denaturation and DSC-derived thermal
transition temperatures. Interestingly, reduced PlyG was able to
retain 33% residual activity after being incubated at 90 1C, and
remained bacteriolytically functional after being subjected to
100 1C heat treatment.
Kinetic half-life at 50 1C and 55 1C
The rate of thermally-induced kinetic inactivation was analyzed
for PlyG at 50 1C and 55 1C in 50 mM sodium phosphate buffer, pH
6.0, supplemented with 200 mM NaCl and 10 mM TCEP. For these
particular experiments, the residual activity of heat-treated PlyG
was determined at various time points over the span of 5 days.
These residual activity values were subsequently normalized to
the lytic activity associated with the endolysin in the absence of
heat treatment. At 50 1C, PlyG exhibited a kinetic half-life (t1/2) of
35 h (R2¼0.9503) (Fig. 7A). At 55 1C, the t1/2 of PlyG was 5.5 h
(R2¼0.9286) (Fig. 7B).
Fig. 5. Thermodynamic stability of the various PlyG constructs. (A) Full-length
PlyG, as well as the (B) EAD and (C) CBD modules, were thermodynamically
characterized using DSC. Each sample was heated from 15 1C to 105 1C and then
immediately cooled over the same temperature range at 1 1C/min in 20 mM
sodium phosphate buffer, pH 6.0. The molar heat capacity (kcal/mol K) was plotted
against the temperature for each sample. For each PlyG construct, individual
thermal transitions (dashed lines), as well as their sum (solid line), are depicted.
Fig. 6. Kinetic inactivation temperature screen. (A) PlyG was incubated at 10 mg/ml
in 50 mM sodium phosphate buffer, pH 6.0, supplemented with 200 mM NaCl, for
10 min at temperatures ranging from 4 1C to 100 1C. The samples were cooled on
ice for 5 min and the residual lytic activity was then assessed using turbidity
reduction assays. (B) In the second set of experiments, the only alteration consisted
of further supplementing the incubation buffer with 10 mM TCEP reducing agent.
All data was expressed as the mean7SEM of triplicate experiments and normal-
ized to lytic activity displayed by the unheated samples.
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Discussion
Results from a biophysical thermal analysis of PlyG suggest this
particular proteinaceous chemotherapeutic is thermostable. Inter-
estingly, the full-length structure was found to be less thermo-
stable than the isolated EAD and CBD modules (Figs. 4 and 5). In
the absence of the targeted cell wall-associated epitope, structural
studies have shown the N-terminal and C-terminal domains of
some endolysins interact to render the enzyme in an inactive state
(Hermoso et al., 2003). Upon binding to its cell wall receptor,
endolysins can undergo structural alterations that ultimately
activate the catalytic mechanism of the enzyme. With this in
mind, it is possible the interaction between the EAD and CBD in
the context of full-length PlyG generates a structural conformation
that is energetically unfavorable when compared to the modiﬁed
structures of the compact, isolated EAD and CBD modules. As
observed with the pneumococcal endolysins Cpl-1 and Pal in the
presence of their cell wall-associated choline receptor, the addition
of the puriﬁed ManNAc-GlcNAc-HexNAc cell wall receptor of PlyG,
followed by subsequent binding by the endolysin, could have
substantial ramiﬁcations on stability, especially if structural mod-
iﬁcations and/or higher oligomerization states are achieved
(Ganguly et al., 2013; Sanz et al., 1993; Varea et al., 2004).
In the absence of reducing agent, PlyG was unexpectedly
kinetically unstable (Fig. 6A). The temperatures at which the
endolysin was displaying sizeable activity defects did not correlate
with the structural and thermal transitions elucidated by the
biophysical experiments. As suggested by the CD thermal dena-
turation experimental results, kinetically inactivating physical
and/or chemical modiﬁcations to PlyG at temperatures less than
60 1C were not stimulated by secondary structure alterations.
Moreover, thermodynamic analysis of PlyG indicated the kinetic
inactivation of the endolysin at temperatures less than 60 1C did
not correspond to any detectable thermal events. From this
information, we rationalized the inactivation of PlyG could be
instigated by the introduction of chemical modiﬁcations to amino
acids, speciﬁcally the oxidation of cysteine and/or methionine
residues, which are required for catalysis, binding, dimerization, or
other processes that affect activity. In this particular scenario, it is
possible these alterations could kinetically inactivate the enzyme
without disrupting secondary structure, and hence would be
undetectable during CD thermal denaturation analysis. Results
from independent studies support this hypothesis. For example,
results from far-UV CD spectroscopy revealed there was no
difference in secondary structure when comparing reduced
human serum albumin (HAS) to oxidized HAS (Sancataldo et al.,
2014). Additionally, it would be possible to overlook these chemi-
cal modiﬁcations by DSC due to the minimal heat capacity change
associated with these chemical processes. As a result, alternative
methods are routinely utilized for detecting amino acid modiﬁca-
tions, including the use of cyanogen bromide cleavage/amino acid
analysis for methionine oxidation detection (Levine et al., 1996;
Maier et al., 1995) and dithiobisnitrobenzoate (i.e. Ellman's
reagent) and SDS-PAGE (7reducing agent) analysis for detecting
disulﬁde formation as a result of cysteine oxidation (Radi et al.,
1991). Our hypothesis was supported when performing a kinetic
inactivation temperature screen of PlyG in buffer environments
that included reducing agent (Fig. 6B). In the presence of TCEP, the
kinetic stability of PlyG was dramatically enhanced to resemble
the kinetic thermoresistance displayed by other highly stable
peptidoglycan hydrolases (Briers et al., 2006, 2008; Schmelcher
et al., 2012b; Ye and Zhang, 2008). Similar results were obtained
when using other reducing agents, such as dithiothreitol and
glutathione (data not shown).
When incubated with reducing agent, PlyG unexpectedly dis-
played residual lytic activity at temperatures exceeding its thermal
denaturation temperature. The prominent difference between the
kinetic stability and biophysical experiments pertains to the buffer
conditions. Unlike the CD and DSC experiments, the kinetic
stability analysis utilized an incubation buffer consisting of NaCl
and reducing agent. Depending on the charge distribution within
the structure, proteins are often stabilized by monovalent salts due
to the increased the ionic strength of the solution (Kohn et al.,
1997; Record et al., 1998; Vonhippel and Wong, 1964). Further-
more, the presence of reducing agent can prevent thermally-
induced protein oxidation, which constitutes a major chemical
degradation pathway that instigates irreversible unfolding of
proteins, and hence improve protein folding reversibility and
stability (Wang and Singh, 2013).
Results from several studies speciﬁc to analyzing the thermal
stability of endolysins collectively suggest these enzymes
lack inherent thermal stability and thus possess limited therapeu-
tic potential. For example, the streptococcal endolysin PlyC dis-
plays an unfolding thermal transition at 48.3 1C and a kinetic half-
life of 18 min at 45 1C (manuscript under review). Results from
kinetic inactivation experiments dictate the Staphylococcus aureus
Fig. 7. Thermal kinetic inactivation half-life experiments. PlyG was incubated at 10 mg/ml in 50 mM sodium phosphate buffer, pH 6.0, supplemented with 200 mM NaCl
and 10 mM TCEP, at either (A) 50 1C or (B) 55 1C for a total of 5 days. At numerous time points, an aliquot was removed from the heat block, cooled and then assayed
by means of turbidity reduction assay to quantitate residual lytic activity. Data was expressed as the mean7SEM of triplicate experiments and normalized to the activity
displayed by PlyG in the absence of heat treatment.
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endolysin LysK is thermally denatured at 42.5 1C (Filatova et al.,
2010). CD thermal denaturation experiments of the staphylococcal
endolysin PlyGRCS revealed the endolysin had a melting tempera-
ture (Tm) of 43.5 1C (Linden et al., 2014). When thermodynamically
evaluated by DSC, the pneumococcal endolysins Cpl-1, Pal and Cpl-
7 manifested thermal denaturation temperatures of 43.5 1C,
50.2 1C and 50.4 1C, respectively, with Pal and Cpl-7 being ana-
lyzed at their optimal pH for stability (Bustamante et al., 2012;
Sanz et al., 1993; Varea et al., 2004). Although information
pertaining to the thermal characteristics of other endolysins is
currently limited, PlyG is the most structurally and thermodyna-
mically stable endolysin characterized to date and thus its various
thermostable domains, as well as structural information pertain-
ing to this enzyme, can be applied to future bioengineering studies
speciﬁc to thermostabilizing other endolysins. Considering the
modular architecture of endolysins that target Gram-positive
microorganisms, the EAD and CBD modules of PlyG can be utilized
for constructing chimeric endolysins with enhanced stability.
Chimeragenesis has been shown to be an effective engineering
approach for modifying various characteristics of endolysins,
including altering EAD cut site speciﬁcity and catalytic efﬁciency,
decreasing susceptibility to resistance formation, and varying
bacterial target speciﬁcity (Croux et al., 1993a, 1993b; Diaz et al.,
1990, 1991; Donovan et al., 2006; Schmelcher et al., 2012a, 2011).
Along these lines, a heat-susceptible EAD or CBD can be replaced
by a thermostable equivalent. For example, the EAD of PlyG can be
used to replace a thermolabile EAD belonging to any Gram-
positive speciﬁc endolysin, whereas the CBD can be substituted
for any unstable B. anthracis-speciﬁc CBD. Alternatively, solving
the crystal structure of PlyG could allow for the identiﬁcation of
unique stabilizing structural characteristics that can then be
incorporated into other heat-susceptible endolysins using
structure-guided site-directed mutagenesis or chimeragenesis.
In addition to characteristics assimilated with PlyG elucidated
by previous in vitro and in vivo studies, the elevated thermal
stability displayed by the endolysin further highlights its anti-
microbial potential. Besides avoiding resistance formation while
establishing antibacterial efﬁcacy in vitro and in vivo against
Bacillus (Schuch et al., 2002), PlyG represents a protein therapeutic
that has prolonged shelf life expectancy. These biomolecular
properties collectively improve the probability of PlyG being
developed for industrial applications over a wide-range of tem-
perature environments.
Materials and methods
Bacterial strains, growth conditions and cell preparation
Escherichia coli strains DH5α and BL21(DE3)pLysS (Novagen)
were grown in Luria-Bertani (LB) broth using either an 18 1C or
37 1C shaking incubator. These strains were supplemented with
ampicillin (100 mg/ml) when appropriate. B. cereus RSVF1 was
grown in brain-heart infusion broth (BHI) at 37 1C until mid-log
phase (OD600¼0.5). The cells were harvested at 4,000 RPM for
15 min and the supernatant media was decanted. The bacteria was
then washed once with enzyme buffer and ﬁnally resuspended to
an OD600 of 2.0.
Molecular cloning
The gamma phage endolysin plyG, GenBank accession no.
AF536823, was codon-optimized by GeneArt (Life Technologies)
for expression in E. coli. The genes encoding plyG, plyG_EAD and
plyG_CBD were ampliﬁed by the polymerase chain reaction (PCR)
using the codon-optimized plyG as a template. Full-length plyG
was ampliﬁed using the primers PlyG-F_EcoRI and PlyG-R_Xbal;
plyG_EAD was ampliﬁed using the primers PlyG-F_EcoRI and
PlyG_EAD-R_XbaI; and plyG_CBD was ampliﬁed using the primers
PlyG_CBD-F_EcoRI and PlyG-R_XbaI (Table 2). The standard PCR
reaction mixture consisted of 1 ng of template, 1X Q5 reaction
buffer, 0.2 mM dNTP mix, 0.5 mM of each primer and 1 U of Q5
DNA polymerase (New England Biolabs). The thermocycler heating
conditions consisted of 98 1C for 30 s, 35 (98 1C for 10 s; 60 1C
for 30 s; 72 1C for 30 s/kb) and 72 1C for 2 min. The ampliﬁed PCR
products were double digested with EcoRI and XbaI restriction
endonucleases, cloned into pBAD24 (Novagen) and transformed
into E. coli DH5α. Each gene was constructed to have a translated
N-terminal MRGSHHHHHHGS tag.
Protein expression and puriﬁcation
E. coli BL21(DE3)pLysS transformed with the expression con-
structs pBAD24::plyG, pBAD24::plyG_EAD or pBAD24::plyG_CBD,
were grown in a 4 L bafﬂed Erlenmeyer ﬂask at 37 1C until the
OD600 reached 1.2–1.5. Protein expression was induced at 18 1C for
16 h with 0.25% L-arabinose. The cells were harvested at 7,000
RPM for 15 min and resuspended in PBS, pH 7.2, supplemented
with 1 mM phenylmethylsulfonyl ﬂuoride (PMSF) and 10 mM
imidazole. The bacteria were sonicated on ice for 15 min, with
the insoluble cellular debris subsequently pelleted at 13,000 RPM
for 1 h at 4 1C. The soluble lysate was applied to a nickel-charged
5 ml Proﬁnity IMAC column (Bio-Rad). The column was washed
independently with PBS, 1 M NaCl and 20 mM 2-(N-morpholino)
ethanesulfonic acid (MES), pH 6.5, to remove unbound or non-
speciﬁcally bound contaminants. Protein samples were eluted
from the IMAC column using a step gradient consisting of
imidazole concentrations ranging from 20 to 500 mM resus-
pended in PBS, pH 7.2. The elution fractions were subjected to
SDS-PAGE. Fractions that contained the protein of interest at high
purity were collected, combined and dialyzed against PBS, pH 7.2,
for 2 h at room temperature and then overnight at 4 1C.
Circular dichroism far-UV and thermal denaturation experiments
Using 1 mm quartz cuvettes, all samples used in the CD studies
were in 20 mM sodium phosphate buffer, pH 6.0–8.0, with a protein
concentration of 0.1 (far-UV CD spectroscopy) or 0.5 (CD thermal
denaturation experiments) mg/ml. This pH range was investigated
since it nearly fulﬁlls the entire buffering capacity of sodium
phosphate buffer, which is pH 5.7–8.0 at room temperature.
Additionally, one particular buffer was utilized to avoid potential
variations in protein structure and stability inﬂuenced by the
chemical composition of different buffers. CD experiments were
conducted using a Chirascan CD Spectrometer (Applied Photophy-
sics) equipped with a temperature control system. The secondary
structure for each protein sample was measured in the far-UV range
(190–260 nm) at 1 nm steps with 5 s signal averaging per data
point. Spectra for each protein sample were collected in triplicate,
followed by averaging, baseline subtraction, smoothing and con-
version to mean residue ellipticity (MRE) by the Pro-Data software
Table 2
Oligonucleotide primers used for PCR.
Primer name Nucleotide sequence
PlyG-F_EcoRI 50-CCGGAATTCATTATGCGTGGTAGCCATCATCATC-30
PlyG-R_XbaI 50-CCCTCTAGATTATTTCACTTCATACCACCAACC-30
PlyG_EAD-R_XbaI 50-CCCTCTAGATTATGCCACATTACCATTTTTCACTTTC-30
PlyG_CBD-F_EcoRI
50-CCGGAATTCATTATGCGTGGTAGCCATCATCATCACCA
TC ATGGTAGCAATGGTAATGTGGCAACCACCAGTCCG-30
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(Applied Photophysics). Using the far-UV spectra as a guide,
qualitatively assessing the secondary structure of each protein
sample was accomplished as previously described (Greenﬁeld and
Fasman, 1969; Kelly et al., 2005). Secondary structure estimations
were calculated using the CONTIN method provided by DICHRO-
WEB (Provencher and Glockner, 1981; Whitmore and Wallace,
2004). Thermal denaturation experiments were performed from
20 1C to 95 1C at 1 1C/min. The MRE at 222 nm, which corresponds
to the α-helical content of the protein, was monitored at 0.5 1C
steps with 5 s signal averaging per data point. The melting data was
smoothened, normalized and ﬁt with a Boltzmann sigmoidal curve.
The ﬁrst derivative of the melting curve was then calculated to
determine the T1/2 (Fallas and Hartgerink, 2012).
Differential scanning calorimetry
DSC measurements of the various PlyG constructs were carried
out with a Nano DSC differential scanning calorimeter (TA Instru-
ments). Sample solutions for DSC measurements consisted of 0.25
(PlyG_CBD) or 0.5 (Full-length PlyG and PlyG_EAD) mg/ml in
20 mM sodium phosphate buffer, pH 6.0. To extend the tempera-
ture range, all DSC measurements were performed under an
excess pressure of 3 atm. The sample and reference cells were
initially calibrated with equal volumes of sample buffer using
three consecutive heating/cooling cycles from 15 1C to 105 1C and
105 1C to 15 1C at 1 1C/min. The protein samples were then heated
from 15 1C to 105 1C at a 1 1C/min heating rate, followed by
immediate cooling from 105 1C to 15 1C at 1 1C/min. Data decon-
volution by means of baseline subtraction and curve ﬁtting was
performed by the NanoAnalyze software (TA Instruments).
Thermally-induced kinetic inactivation of PlyG
For the kinetic inactivation temperature screens, 50 mM sodium
phosphate buffer, pH 6.0, supplemented with 200 mM NaCl and, for
one set of experiments, 10 mM TCEP, was equilibrated on a heat
block at temperatures ranging from 4 1C to 100 1C for 10 min. Unlike
the CD and DSC experiments, NaCl was added to the sodium
phosphate buffer due to the salt-dependence for lytic activity dis-
played by PlyG (data not shown). Ice-cold PlyG was then added to
the heated buffers at a ﬁnal concentration of 10 mg/ml, vortexed
gently and then incubated for an additional 10 min. The enzyme
sample, which consists of a total volume of 400 ml in a 1.5 ml
polypropylene tube, was then removed from the heat block and
incubated on ice. 100 ml of the heat-treated PlyG sample was
aliquoted into three adjacent wells of a 96-well microtiter plate.
B. cereus RSVF1 cells (see Bacterial Strains, Growth Conditions and
Cell Preparation) were added at an equal volume to PlyG samples
residing in the microtiter plate, resulting in ﬁnal PlyG and B. cereus
concentrations of 5 mg/ml and OD600¼1.0, respectively. The residual
bacteriolytic activity of the PlyG enzymes were assessed by a
microplate spectrophotometer (Molecular Devices), where the
OD600 was measured every 15 s for 30 min at 37 1C. Endolysin
activity was equated to the Vmax corresponding to the linear
portion of the resulting killing curve. Data was expressed as the
mean7SEM of triplicate experiments and normalized to the
activity displayed by the unheated PlyG sample.
For the 50 1C and 55 1C half-life experiments, 50 mM sodium
phosphate buffer, pH 6.0, supplemented with 200 mM NaCl and
10 mM TCEP, was initially aliquoted at equal volumes into 111.5 ml
polypropylene tubes for each experiment. The buffer samples were
equilibrated at either 50 1C or 55 1C for 10 min. An additional
buffer sample, which serves as the unheated control, was placed
on ice. Ice-cold PlyG was then added to each sample to achieve a
respective ﬁnal volume and concentration of 400 ml and 10 mg/ml
per tube. A PlyG sample was removed from the heating block
every hour for the ﬁrst 6 h, then once every 24 h for the next ﬁve
days. All of the samples were immediately cooled on ice and then
stored at 4 1C until the 5 day heat incubation was complete. Next,
100 ml from each PlyG sample was aliquoted into three adjacent
wells in a 96-well microtiter plate. 100 ml of B. cereus RSVF1 cells
were added to each PlyG sample. Residual activity was determined
as previously described for the kinetic inactivation temperature
screen experiments.
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